Initial combination therapy plays a central role in managing pulmonary arterial hypertension (PAH) [1–4]. Patients with low- or intermediate-risk of 1-year mortality at diagnosis should be
Read more
To determine how cardiologists manage medical treatment in HF patients after hospital discharge, according to LVEF…
The aim of the Eclat survey was to evaluate the frequency of frailty in uncontrolled hypertensives and to individualize different frailty profiles…
The aim of the Impact-Reco programme was to analyse prescription rates of CHF drugs in stable outpatients with CHF related to left ventricular (LV)…
The purpose of this research was to review the literature on masked hypertension. Studies, reviews and editorials on masked hypertension were identified…
To determine prescription rates of CHF drugs, and to assess predictive factors for drug prescription using data from a large panel of French…
To describe, according to the type of first-line antihypertensive monotherapy (FLAM) the persistence rate and the cumulative probability of its potential…
The aim of this work is to better define the clinical profile of masked hypertensives within a population with controlled office blood pressure (BP) and…
To evaluate the prevalence and reproducibility of MH after excluding confusing factors [method and time of blood pressure (BP) measurement, …
We tried to determine the prognostic impact of triple (antiplatelet agents, statins and beta-blockers) and quadruple (the same+ACE inhibitors)…
